Hints and tips:
...Last month Carlyle, the Washington-based private equity group, won a fiercely competitive auction to take over Akzo Nobel’s €10.1bn specialty chemicals unit after the business became a takeover target....
...Carlyle wins fight for Akzo Nobel speciality chemicals arm A group of investors led by US buyout giant Carlyle agreed to pay €10.1bn including debt for Akzo Nobel’s specialty chemicals unit after months...
...Yet, just two years ago Teva was the picture of health. On Monday the company reached for a favourite remedy. Kare Schultz of Lundbeck will become Teva’s fourth chief executive in a decade....
...owner joins race for £200m Rapha (Sky News) Louis Dreyfus Company sells African fertiliser business (FT) Mitsubishi Tanabe to pay $1.1bn for Israeli drugmaker (FT) India’s UPL explores bid for Platform Specialty...
...Oncology drugs, particularly new treatments that take advantages of innovations in genomics to make targeted therapies, are seen as critical elements to larger pharma companies’ portfolios, making specialty...
...Oncology medicines, particularly new treatments that take advantage of innovations in genomics to produce targeted therapies, are seen as critical elements to larger pharma companies’ portfolios, making specialty...
...He is a Director of Beyond Luxury Watch Boutique Pvt. Ltd., Physicians Practice Management, and MDTablet, LLC....
...“The key M&A trends in 2014 and 2015 were specialty pharma companies acquiring revenue and cutting costs using cheap debt. That has disappeared....
...The chemicals roll-up, Platform Specialty Products, and a consumer products conglomerate, Nomad Foods, are both down by about two-thirds....
...Among Serco’s troubled outsourcing deals was a three-year £140m contract to take over nearly all community health services in Suffolk, which was awarded in 2012....
...However, it remains unclear if Mr Yadav’s gift has the backing of the board or how it will affect the long-term health of the company. SoftBank declined to comment....
...A successful bid for Mylan would allow Teva, the world’s largest generic drugmaker, to create a company with annual revenues of more than $30bn and establish a leading position in the “specialty” drugs market...
...per cent last year, according to Express Scripts, the largest pharmacy-benefits manager, compared with a 5.6 per cent jump in overall US healthcare costs, partly because a new generation of expensive “specialty...
...Aside from any immediate gains, Teva’s move on Mylan can also been seen as a response to consolidation in the health services sector....
...Related Links: Hermes i tickets Private ltd – Financials to March 2014...
...If combined, over 40 per cent of Teva-Mylan’s revenues would come from so-called “specialty” drugs rather than low-margin copycat pills, underscoring the trend of generic makers moving into more profitable...
...Discovery Health is South Africa’s largest private insurance administrator offering rewards – such as frequent-flyer-style points and reductions on exotic holidays – for healthy lifestyles....
...Shares in Aspen Insurance Holdings rallied 11.25 per cent after rejecting a $3.2bn hostile bid by rival Endurance Specialty Holdings, dubbing it “ill-conceived” with “significant execution risk” and a “strategic...
...The proposed initial public offering of Medibank Private Ltd. marks the beginning of the federal government’s drive to sell assets and generate funds that can pay for new infrastructure such as roads and...
...Most recently Mylan, the US-based generic maker, was given the regulatory go ahead for the $1.6bn acquisition of Agila Specialties, the Indian vaccine and injectables producer....
...India’s government has given the go-ahead for US-based pharmaceutical company Mylan’s long-stalled $1.6bn acquisition of Indian vaccine and injectable-drug maker Agila Specialties, after months of internal...
...by a UN resolution and if there is proof “beyond doubt” that President Bashar al-Assad used chemical weapons. http://on.ft.com/15xY9IN India crisis threatens big hit on banks Fears are rising for the health...
...Formed in Manchester, The Smiths were the most important indie band of the 1980s, an alternative to the glossy pop dominating the charts....
...“Meda regularly appears as a buyout candidate in a global Specialty Pharma sector that is subject to ongoing consolidation,” said analysts at Swedbank in a note....
International Edition